| ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ... European heart journal 32 (23), 2999-3054, 2011 | 4978 | 2011 |
| Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Authors/Task Force Members, K Fox, MAA Garcia, D Ardissino, ... European heart journal 27 (11), 1341-1381, 2006 | 2188 | 2006 |
| Everolimus-eluting stents or bypass surgery for left main coronary artery disease GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, ... New England Journal of Medicine 375 (23), 2223-2235, 2016 | 1160 | 2016 |
| Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial S Windecker, PW Serruys, S Wandel, P Buszman, S Trznadel, A Linke, ... The Lancet 372 (9644), 1163-1173, 2008 | 786 | 2008 |
| Comparison of zotarolimus-eluting and everolimus-eluting coronary stents PW Serruys, S Silber, S Garg, RJ van Geuns, G Richardt, PE Buszman, ... New England journal of medicine 363 (2), 136-146, 2010 | 767 | 2010 |
| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 710 | 2018 |
| Five-year outcomes after PCI or CABG for left main coronary disease GW Stone, AP Kappetein, JF Sabik, SJ Pocock, MC Morice, J Puskas, ... New England Journal of Medicine 381 (19), 1820-1830, 2019 | 709 | 2019 |
| Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ... Circulation 118 (11), 1172-1182, 2008 | 668* | 2008 |
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left … M Tendera, W Wojakowski, W Rużyłło, L Chojnowska, C Kępka, W Tracz, ... European heart journal 30 (11), 1313-1321, 2009 | 550 | 2009 |
| Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization PE Buszman, SR Kiesz, A Bochenek, E Peszek-Przybyla, I Szkrobka, ... Journal of the American College of Cardiology 51 (5), 538-545, 2008 | 507 | 2008 |
| Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS … GG Stefanini, B Kalesan, PW Serruys, D Heg, P Buszman, A Linke, ... The Lancet 378 (9807), 1940-1948, 2011 | 420 | 2011 |
| Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in … PW Serruys, V Farooq, B Kalesan, T De Vries, P Buszman, A Linke, ... JACC: Cardiovascular Interventions 6 (8), 777-789, 2013 | 369 | 2013 |
| Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study J Escaned, C Collet, N Ryan, G Luigi De Maria, S Walsh, M Sabate, ... European heart journal 38 (42), 3124-3134, 2017 | 310 | 2017 |
| Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial JJ Wykrzykowska, S Garg, C Girasis, T De Vries, MA Morel, GA Van Es, ... Journal of the American College of Cardiology 56 (4), 272-277, 2010 | 284 | 2010 |
| Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction W Wojakowski, M Tendera, M Kucia, E Zuba-Surma, E Paczkowska, ... Journal of the American College of Cardiology 53 (1), 1-9, 2009 | 283 | 2009 |
| Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the … V Džavík, CE Buller, GA Lamas, JM Rankin, GBJ Mancini, WJ Cantor, ... Circulation 114 (23), 2449-2457, 2006 | 225 | 2006 |
| 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A … M Taniwaki, GG Stefanini, S Silber, G Richardt, P Vranckx, PW Serruys, ... Journal of the American College of Cardiology 63 (16), 1617-1625, 2014 | 199 | 2014 |
| Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry PE Buszman, PP Buszman, RS Kiesz, A Bochenek, B Trela, ... Journal of the American College of Cardiology 54 (16), 1500-1511, 2009 | 183 | 2009 |
| Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass … A Chieffo, E Meliga, A Latib, SJ Park, Y Onuma, P Capranzano, ... JACC: Cardiovascular Interventions 5 (7), 718-727, 2012 | 172 | 2012 |
| Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial PE Buszman, PP Buszman, I Banasiewicz-Szkróbka, KP Milewski, ... Cardiovascular Interventions 9 (4), 318-327, 2016 | 171 | 2016 |
